お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
950907

医薬品:世界の業界年間 (2015-2024年)

Pharmaceuticals Global Industry Almanac 2015-2024

出版日: | 発行: MarketLine | ページ情報: 英文 552 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
医薬品:世界の業界年間 (2015-2024年)
出版日: 2020年06月30日
発行: MarketLine
ページ情報: 英文 552 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品業界における総収益は、2019年に1兆575億1310万米ドルとなり、2015年から2019年にかけては3.6%のCAGRを示しました。米国、中国、日本は、ドイツ、フランス、スペイン、イタリアなどの欧州の大規模市場と並んで、世界最大の医薬品市場の1つです。

当レポートでは、世界の医薬品業界について調査し、業界の規模 (実績値・予測値) を含む定性的・定量的な情報、主要地域・国別の分析、および主要企業のプロファイルなどを提供しています。

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 世界の医薬品

第4章 アジア太平洋地域の医薬品

第5章 欧州の医薬品

第6章 フランスの医薬品

第7章 ドイツの医薬品

第8章 オーストラリアの医薬品

第9章 ブラジルの医薬品

第10章 カナダの医薬品

第11章 中国の医薬品

第12章 インドの医薬品

第13章 インドネシアの医薬品

第14章 イタリアの医薬品

第15章 日本の医薬品

第16章 メキシコの医薬品

第17章 オランダの医薬品

第18章 北米の医薬品

第19章 ロシアの医薬品

第20章 スカンジナビア諸国の医薬品

第21章 シンガポールの医薬品

第22章 南アフリカの医薬品

第23章 韓国の医薬品

第24章 スペインの医薬品

第25章 トルコの医薬品

第26章 英国の医薬品

第27章 米国の医薬品

第28章 企業プロファイル

第29章 付録

図表

List of Tables

  • Table 1: Global pharmaceuticals market value: $ billion, 2015-19
  • Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 3: Global pharmaceuticals market share: % share, by value, 2019
  • Table 4: Global pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 5: Global size of population (million), 2015-19
  • Table 6: Global gdp (constant 2005 prices, $ billion), 2015-19
  • Table 7: Global gdp (current prices, $ billion), 2015-19
  • Table 8: Global inflation, 2015-19
  • Table 9: Global consumer price index (absolute), 2015-19
  • Table 10: Global exchange rate, 2015-19
  • Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19
  • Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2019
  • Table 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 15: Europe pharmaceuticals market value: $ billion, 2015-19
  • Table 16: Europe pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 17: Europe pharmaceuticals market share: % share, by value, 2019
  • Table 18: Europe pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 19: Europe size of population (million), 2015-19
  • Table 20: Europe gdp (constant 2005 prices, $ billion), 2015-19
  • Table 21: Europe gdp (current prices, $ billion), 2015-19
  • Table 22: Europe inflation, 2015-19
  • Table 23: Europe consumer price index (absolute), 2015-19
  • Table 24: Europe exchange rate, 2015-19
  • Table 25: France pharmaceuticals market value: $ billion, 2015-19
  • Table 26: France pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 27: France pharmaceuticals market share: % share, by value, 2019
  • Table 28: France pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 29: France size of population (million), 2015-19
  • Table 30: France gdp (constant 2005 prices, $ billion), 2015-19
  • Table 31: France gdp (current prices, $ billion), 2015-19
  • Table 32: France inflation, 2015-19
  • Table 33: France consumer price index (absolute), 2015-19
  • Table 34: France exchange rate, 2015-19
  • Table 35: Germany pharmaceuticals market value: $ billion, 2015-19
  • Table 36: Germany pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 37: Germany pharmaceuticals market share: % share, by value, 2019
  • Table 38: Germany pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 39: Germany size of population (million), 2015-19
  • Table 40: Germany gdp (constant 2005 prices, $ billion), 2015-19
  • Table 41: Germany gdp (current prices, $ billion), 2015-19
  • Table 42: Germany inflation, 2015-19
  • Table 43: Germany consumer price index (absolute), 2015-19
  • Table 44: Germany exchange rate, 2015-19
  • Table 45: Australia pharmaceuticals market value: $ billion, 2015-19
  • Table 46: Australia pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 47: Australia pharmaceuticals market share: % share, by value, 2019
  • Table 48: Australia pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 49: Australia size of population (million), 2015-19
  • Table 50: Australia gdp (constant 2005 prices, $ billion), 2015-19
  • Table 51: Australia gdp (current prices, $ billion), 2015-19
  • Table 52: Australia inflation, 2015-19
  • Table 53: Australia consumer price index (absolute), 2015-19
  • Table 54: Australia exchange rate, 2015-19
  • Table 55: Brazil pharmaceuticals market value: $ billion, 2015-19
  • Table 56: Brazil pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 57: Brazil pharmaceuticals market share: % share, by value, 2019
  • Table 58: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 59: Brazil size of population (million), 2015-19

List of Figures

  • Figure 1: Global pharmaceuticals market value: $ billion, 2015-19
  • Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 3: Global pharmaceuticals market share: % share, by value, 2019
  • Figure 4: Global pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 5: Forces driving competition in the global pharmaceuticals market, 2019
  • Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2019
  • Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2019
  • Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2019
  • Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2019
  • Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2019
  • Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19
  • Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2019
  • Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2019
  • Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2019
  • Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2019
  • Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2019
  • Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2019
  • Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2019
  • Figure 21: Europe pharmaceuticals market value: $ billion, 2015-19
  • Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 23: Europe pharmaceuticals market share: % share, by value, 2019
  • Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2019
  • Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2019
  • Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2019
  • Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2019
  • Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2019
  • Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2019
  • Figure 31: France pharmaceuticals market value: $ billion, 2015-19
  • Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 33: France pharmaceuticals market share: % share, by value, 2019
  • Figure 34: France pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 35: Forces driving competition in the pharmaceuticals market in France, 2019
  • Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2019
  • Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2019
  • Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2019
  • Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2019
  • Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2019
  • Figure 41: Germany pharmaceuticals market value: $ billion, 2015-19
  • Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 43: Germany pharmaceuticals market share: % share, by value, 2019
  • Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2019
  • Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2019
  • Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2019
  • Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2019
  • Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2019
  • Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2019
  • Figure 51: Australia pharmaceuticals market value: $ billion, 2015-19
  • Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 53: Australia pharmaceuticals market share: % share, by value, 2019
  • Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2019
  • Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2019
  • Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2019
  • Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2019
  • Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2019
  • Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2019
目次
Product Code: MLIG200014-01

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).

Any currency conversions used in the production of this report have been calculated at constant 2019 annual average exchange rates.

Figures presented in this report are calculated applying the "middle path" scenario - this is based on the current situation in countries where the epidemic burst first, like China as a model countries and the announcements made by governments, stating that the abnormal situation may last up to six months.

The assumption has been made that after this time the economy will gradually go back to the levels recorded before the pandemics by the end of the year. It is also assumed that there is no widespread economic crisis as seen back in 2008 due to announced pay-outs across countries.

At the moment of preparation of this report in April 2020 the economic implications of the lock downs of many economics are still very difficult to predict as there is no indication how long the pandemics could last, the number of sectors forced to stay closed and the scale of the governmental' aid involved. At the same time the weight of the pandemic seriousness is applied on the individual countries in this report based on death to population ratio recorded in countries.

Majority of the industries will see the decline in volume of the goods and services offered by companies. Usually the lower demand would cause the decrease the prices level. However, amid many governments' ordered for many industries to lock down and so the supply chain is distorted that in great pictures mitigate the results of lower demand.

Applied scenarios differ depending on the individual sector, however generally sectors which involves intensive manual labor and face to face interaction seem to be hit the most by present situation. On the other hand the internet based businesses as well as the producers of the vital, subsisted products and services seems to take advantages of the current events.

The global pharmaceuticals market had total revenues of $1,057,513.1m in 2019, representing a compound annual growth rate (CAGR) of 3.6% between 2015 and 2019.

The United States, China, and Japan are some of the largest pharmaceutical markets globally, alongside large European markets such as Germany, France, Spain, and Italy.

Historically, China is producing some of the strongest growth every year, whilst the European markets have been stifled due to current healthcare spending cultures in the region.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
  • Reasons to Buy
  • What was the size of the global pharmaceuticals market by value in 2019?
  • What will be the size of the global pharmaceuticals market in 2024?
  • What factors are affecting the strength of competition in the global pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global pharmaceuticals market?

Table of Contents

1. EXECUTIVE SUMMARY

2. Introduction

3. Global Pharmaceuticals

4. Pharmaceuticals in Asia-Pacific

5. Pharmaceuticals in Europe

6. Pharmaceuticals in France

7. Pharmaceuticals in Germany

8. Pharmaceuticals in Australia

9. Pharmaceuticals in Brazil

10. Pharmaceuticals in Canada

11. Pharmaceuticals in China

12. Pharmaceuticals in India

13. Pharmaceuticals in Indonesia

14. Pharmaceuticals in Italy

15. Pharmaceuticals in Japan

16. Pharmaceuticals in Mexico

17. Pharmaceuticals in The Netherlands

18. Pharmaceuticals in North America

19. Pharmaceuticals in Russia

20. Pharmaceuticals in Scandinavia

21. Pharmaceuticals in Singapore

22. Pharmaceuticals in South Africa

23. Pharmaceuticals in South Korea

24. Pharmaceuticals in Spain

25. Pharmaceuticals in Turkey

26. Pharmaceuticals in The United Kingdom

27. Pharmaceuticals in The United States

28. Company Profiles

29. Appendix

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.